相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease
Erwin Dreesen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis
Niharika Nalagatla et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD
Renaud Gaujoux et al.
GUT (2019)
Infliximab Exposure-Response Relationship and Thresholds Associated With Endoscopic Healing in Patients With Ulcerative Colitis
Niels Vande Casteele et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
Matthew C. Choy et al.
INFLAMMATORY BOWEL DISEASES (2019)
Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis
David Kevans et al.
JOURNAL OF CROHNS & COLITIS (2018)
Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy
H. Bar-Yoseph et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn's Disease Is Determined by Their Concentration
Helena Edlund et al.
AAPS JOURNAL (2017)
American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases
Niels Vande Casteele et al.
GASTROENTEROLOGY (2017)
Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease
Sine Buhl et al.
INFLAMMATORY BOWEL DISEASES (2017)
P623 Therapeutic preferences and outcomes in newly diagnosed patient with inflammatory bowel diseases in the biological era in Hungary. A nationwide study based on the National Health Insurance Fund database
L. Gonczi et al.
Journal of Crohns & Colitis (2017)
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
Kristin K. Jorgensen et al.
LANCET (2017)
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
Andres J. Yarur et al.
GUT (2016)
First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis
Taku Kobayashi et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
Johannan F. Brandse et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis
Konstantinos Papamichael et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies
Casper Steenholdt et al.
INFLAMMATORY BOWEL DISEASES (2016)
Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab
Konstantinos Papamichael et al.
JOURNAL OF CROHNS & COLITIS (2016)
Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease
Casper Steenholdt et al.
MEDICINE (2016)
An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis
David J. Gibson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab
Casper Steenholdt et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
Johannan F. Brandse et al.
GASTROENTEROLOGY (2015)
Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD: Evolution in the Definition and Management of Primary Nonresponse
Konstantinos Papamichael et al.
INFLAMMATORY BOWEL DISEASES (2015)
Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
Omoniyi J. Adedokun et al.
GASTROENTEROLOGY (2014)
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial
Casper Steenholdt et al.
GUT (2014)
Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease
C. Steenholdt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis
Trine Olsen et al.
CYTOKINE (2009)
Review article: biological activity markers in inflammatory bowel disease
D. Desai et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
分享论文
